Fig. 8From: In silico prediction and structure-based multitargeted molecular docking analysis of selected bioactive compounds against mucormycosis3D visualisation of docking analysis of Mucoricin binding with 12,28-oxamanzamine A (a), manzamine A (b), parsiguine (c), halicyclamine A (d), tetrahydrohaliclonacyclamine A (e), Phaeosphenone (f), 6-deoxymanzamine X (g), goniodomin A (h), hesperidin (i), stelletin A (j)Back to article page